GH · earnings call history
Guardant Health Q2 FY26 — Strong Growth Across Segments, Key Shield Milestones, and FDA Approvals
Read the briefGuardant Health Q1 FY26 — Strong Revenue Growth and Shield Momentum
Read the briefBrowse all US companies on the earnings-call register.